With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Four companies from an industry with little to no Columbus-area presence in 2020 now have a combined 1,200 high-paying jobs.

MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying ...

Amgen, based in Thousand Oaks, California, first broke ground in New Albany in 2021. Here's how the company plans to expand.

As the National Science Foundation faces an existential threat from DOGE and the Trump administration, Congress has yet ...

MassBio CEO Kendalle Burlin O’Connell said that without "policy stability and renewed investment," we will cede leadership in ...

The state of Connecticut “WARN” site that reports such layoffs indicates that 92 of the people to be laid off are state ...

Lorenzo Paoletti, managing director, Biotech Investment Banking at Truist Securities, discussed the effects of recent job cuts and restructuring of the regulatory agencies with GEN Edge.

New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued ...

In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...